Haematologica (Sep 2023)
Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant
Abstract
No abstracts available.
Haematologica (Sep 2023)